CATALYST PHARMACEUTICALS, INC. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Product revenue, net
License and other revenue
Total revenues
Operating costs and expenses:
Cost of sales
Research and development
Selling, general and administrative
Amortization of intangible assets
Total operating costs and expenses
Operating income
Other income, net
Net income before income taxes
Income tax provision
Net income
Other comprehensive income (Note 4):
Unrealized gain (loss) on available-for-sale securities, net of tax of $0, ($20) and $4, respectively
Comprehensive income
Net income per share:
Basic
Diluted
Weighted average shares outstanding:
Basic
Diluted

Comments